Skip the Northern Ireland Government Bar|

Northern Ireland Government >

Chief Medical Officer Public Health and R&D

CMO - Annual Reports

Facts and Figures

Professional Medical and Environmental Health Advice

HSS Letters and Urgent Communications

Letters and Urgent Communications 2010

Letters and Urgent Communications 2009

Letters and Urgent Communications 2008

Letters and Urgent Communications 2007

Letters and Urgent Communications 2006

Letters and Urgent Communications 2005

Letters and Urgent Communications 2004

Letters and Urgent Communications 2003

Letters and Urgent Communications 2002

> Letters and Urgent Communications 2001

Letters and Urgent Communications 2000

CMO Updates

Latest Information Guidance for HSC/professional staff

Environmental Health

Health Service Reviews

Professional Good Practice Guidelines

Professional Regulation and Development

Specialist Medicines

Public Health Policy

Safety, Quality and Standards

Letters and Urgent Communications

2001

HSS(MD) 38/01 18 December 2001 (PDF 121 KB)
Emergency Planning

HSS(MD) 35/01 - 04/12/01 (PDF 49 KB)
Diathermy for Tonsil or Adenoid Surgery

HSS(MD) 32/01 - 20/11/01 (PDF 35 KB)
Adventis Pasteur MSD

HSS (MD) 28/01 - 17 October 2001 (PDF 56 KB)
Dealing With Patients Exposed to Suspicious Substances

HSS (MD) 27/01 - 17 October 2001 (PDF 69 KB)
Dealing With Patients Exposed to Suspicious Substances

HSS(MD) 23/01 - 12/11/01 (PDF 22 KB)
Pre-school Acellular Pertussis Booster

HSS(MD) 22/01 - 16/08/01 (PDF 14 KB)
SMA Infant Formula Product Recall of Specific Batches

HSS(MD) 20/01 - 30/07/01 (PDF 72 KB)
Guidance on the the of Cyclo-oxygenase(cox)11 Selective Inhibitors, Celecoxib, Rofecoxib, Melocicam and Rheumatoid Arthritis (nice technology appraisal guidance number 27)

HSS(MD) 18/01 - 15/06/01 (PDF 33 KB)
Influenza Immunisation for Winter 2001/02

HSS(MD) 16/01 - 12/06/01 (PDF 13 KB)
Investigation into retained Organs

HSS(MD) 14/01 - 11/05/01 (PDF 85 KB)
Withdrawal of Anorectic Agents/Appetite Suppressants Amfepramone (Dethlpropion, Tenuate, Dospan) and Phentermine, (Duromine, Ionamin)

HSS(MD) 15/01 - 31/05/01 (PDF 263 KB)
ZYBAN (Amfebutamone/ Bupropion Hydrochloride) Modified Dosage and Safety Precautions

HSS(MD) 09/01 - 12/03/01 (PDF 126 KB)
Diabetes Imminent Phase Out of Insulin Products by Lilly

HSS(MD) 11/01 - 28/03/01 (PDF 20 KB)
MMR Information for Parents and Health Professionals

HSS(MD) 08/01 - March 2001 (PDF 50 KB)
Quality in Family Planning in Northern Ireland

HSS(MD) 04/01 - 16/03/01 (PDF 332 KB)
Risk Assessment on the Risk of vCJD Transmission via Surgical Instruments

HSS(MD) 07/01 - 14/02/01 (PDF 93 KB)
Current Vaccine and immunisation Issues

HSS(MD) 06/01 - 01/02/01 (PDF 56 KB)
Single Use for Tonsillectomy and Adenoidectomy

HSS(MD) 03/01 - 25/01/01 (PDF 61 KB)
Retention of Organs Following Post Mortems

HSS(MD) 02/01 - 16/01/01 (PDF 102 KB)
Patient Enquiries about Depleted Uranium (du) Exposure

HSS (MD) 01/01 - 12 January 2001 (PDF 20 KB)
Update on MMR Vaccine